Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer

Authors

Valerie Blanc, Washington University School of Medicine in St. Louis
Jesse D Riordan, Pacific Northwest Research Institute
Saeed Soleymanjahi, Washington University School of Medicine in St. Louis
Joseph H Nadeau, Pacific Northwest Research Institute
ILKe Nalbantoglu, Yale University
Yan Xie, Washington University School of Medicine in St. Louis
Elizabeth A Molitor, Washington University School of Medicine in St. Louis
Blair B Madison, Washington University School of Medicine in St. Louis
Elizabeth M Brunt, Washington University School of Medicine in St. Louis
Jason C Mills, Washington University School of Medicine in St. Louis
Deborah C Rubin, Washington University School of Medicine in St. Louis
Irene O Ng, University of Hong Kong
Yeonjung Ha, Mayo Clinic College of Medicine and Science
Lewis R Roberts, Mayo Clinic College of Medicine and Science
Nicholas O Davidson, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2021

Volume

131

Issue

1

Document Type

Open Access Publication

DOI

10.1172/JCI138699

Rights and Permissions

Blanc V, Riordan JD, Soleymanjahi S, et al. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. J Clin Invest. 2021;131(1):e138699. doi:10.1172/JCI138699

Recommended Citation

Blanc, Valerie; Riordan, Jesse D; Soleymanjahi, Saeed; Nadeau, Joseph H; Nalbantoglu, ILKe; Xie, Yan; Molitor, Elizabeth A; Madison, Blair B; Brunt, Elizabeth M; Mills, Jason C; Rubin, Deborah C; Ng, Irene O; Ha, Yeonjung; Roberts, Lewis R; and Davidson, Nicholas O, "Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer." The Journal of Clinical Investigation. 131, 1. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10036